Freeline to participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Published 10 Sep 2020

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that Theresa Heggie, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on September 15 at 8.00 am EDT.

A live audio webcast of the fireside chat will be available on the investor relations section of Freeline’s website at https://www.freeline.life/investors-media/. An archived replay will be available on the Company’s website for a period of 30 days after the conference.